ARCHIVES

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

Five-year Childhood ALL Survival Increased To 90.4 Percent by 2005

March 30, 2012

DCT Board Approves Recompetition Of Drug Development Contracts

June 25, 1993

Letter In Response To Hadley; RFA Available

July 7, 1995

Mayer Will Emphasize Rehab Research While Serving On NCAB

May 24, 1991

ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma

May 25, 2007

DCCP Board Oks Fur New Concepts

July 17, 1981